Not recruiting
Registered drugNo placebo
Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Find therapies in clinical trials near you – page 852
- recruiting
- 3 968
- countries
- 0
- conditions
- 0
3 968 trials recruiting0 European countries0 conditions coveredUpdated today
10 282 trials match your criteria
Not recruiting
Study on the Effects of Mebufotenin (GH001) for Patients with Treatment-Resistant Depression
Not recruitingInvestigational
Study on the Effects of Mebufotenin (GH001) for Patients with Treatment-Resistant Depression
Investigational
- Substances:–
- Participants:18–64 years
Not recruiting
Registered drugNo placebo
Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Registered drugNo placebo
Study of Selinexor for Patients with Previously Treated Myelofibrosis
Registered drugNo placebo
- Substances:–
- Participants:18–64 years
Not recruiting
Study of Pembrolizumab and Azacitidine for Patients with Acute Myeloid Leukemia Facing Imminent Relapse
Not recruitingRegistered drugNo placebo
Study of Pembrolizumab and Azacitidine for Patients with Acute Myeloid Leukemia Facing Imminent Relapse
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Study on High-Intensity Focused Ultrasound and Leuprorelin Acetate for Intermediate Risk Prostate Cancer Patients
Not recruitingRegistered drugNo placebo
Study on High-Intensity Focused Ultrasound and Leuprorelin Acetate for Intermediate Risk Prostate Cancer Patients
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Not recruitingRegistered drugNo placebo
Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Study of Bintrafusp Alfa and Doxorubicin Hydrochloride for Adults with Advanced Soft-Tissue Sarcoma
Not recruitingRegistered drugNo placebo
Study of Bintrafusp Alfa and Doxorubicin Hydrochloride for Adults with Advanced Soft-Tissue Sarcoma
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Registered drugNo placebo
Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Registered drugNo placebo
Study on the Effectiveness of Sodium Chloride and Sodium Citrate in Intensive Care Patients Undergoing Continuous Kidney Purification
Registered drugNo placebo
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Study on Rivaroxaban for Stabilizing Carotid Artery Plaques in Patients with Stable Peripheral Artery Disease
Not recruitingRegistered drug
Study on Rivaroxaban for Stabilizing Carotid Artery Plaques in Patients with Stable Peripheral Artery Disease
Registered drug
- Substances:–
- Participants:18–64 years · 65+ years
Not recruiting
Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation
Not recruitingInvestigationalNo placebo
Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation
InvestigationalNo placebo
- Substances:–
- Participants:18–64 years